Files in this item
Hepatic glutamine synthetase controls N5-methylglutamine in homeostasis and cancer
Item metadata
dc.contributor.author | Villar, VH | |
dc.contributor.author | Allega, MF | |
dc.contributor.author | Deshmukh, R | |
dc.contributor.author | Ackermann, T | |
dc.contributor.author | Nakasone, MA | |
dc.contributor.author | Vande Voorde, J | |
dc.contributor.author | Drake, TM | |
dc.contributor.author | Oetjen, J | |
dc.contributor.author | Bloom, A | |
dc.contributor.author | Nixon, C | |
dc.contributor.author | Müller, M | |
dc.contributor.author | May, S | |
dc.contributor.author | Tan, EH | |
dc.contributor.author | Vereecke, L | |
dc.contributor.author | Jans, M | |
dc.contributor.author | Blancke, G | |
dc.contributor.author | Murphy, DJ | |
dc.contributor.author | Huang, DT | |
dc.contributor.author | Lewis, DY | |
dc.contributor.author | Bird, TG | |
dc.contributor.author | Sansom, OJ | |
dc.contributor.author | Blyth, K | |
dc.contributor.author | Sumpton, D | |
dc.contributor.author | Tardito, S | |
dc.date.accessioned | 2023-09-19T10:30:01Z | |
dc.date.available | 2023-09-19T10:30:01Z | |
dc.date.issued | 2023-03 | |
dc.identifier | 292295121 | |
dc.identifier | 290938fd-f14e-4159-b609-0ec99f055404 | |
dc.identifier | 000871287500004 | |
dc.identifier | 36280791 | |
dc.identifier | 85140402973 | |
dc.identifier.citation | Villar , VH , Allega , MF , Deshmukh , R , Ackermann , T , Nakasone , MA , Vande Voorde , J , Drake , TM , Oetjen , J , Bloom , A , Nixon , C , Müller , M , May , S , Tan , EH , Vereecke , L , Jans , M , Blancke , G , Murphy , DJ , Huang , DT , Lewis , DY , Bird , TG , Sansom , OJ , Blyth , K , Sumpton , D & Tardito , S 2023 , ' Hepatic glutamine synthetase controls N 5 -methylglutamine in homeostasis and cancer ' , Nature Chemical Biology , vol. 19 , no. 3 , pp. 292-304 . https://doi.org/10.1038/s41589-022-01154-9 | en |
dc.identifier.issn | 1552-4450 | |
dc.identifier.other | ORCID: /0000-0003-2837-5018/work/140361367 | |
dc.identifier.other | PubMedCentral: PMC9974483 | |
dc.identifier.uri | https://hdl.handle.net/10023/28421 | |
dc.description | Funding: This work was funded by Cancer Research UK awards A17196 and A31287 (CRUK Beatson Institute), Cancer Research UK RadNet Glasgow Centre award A28803 (A.B.), Wellcome Trust grant WT107492Z (T.G.B. and M.M.), Cancer Research UK HUNTER accelerator award A26813 (E.H.T.), Cancer Research UK award A25045 and DRCQQR-May21\100002 (O.J.S.), Cancer Research UK award A29256 (D.T.H.), Cancer Research UK award A29799 (K.B.), Cancer Research UK award A25006 (D.Y.L.) and Cancer Research UK award A23982 (S.T.). | en |
dc.description.abstract | Glutamine synthetase (GS) activity is conserved from prokaryotes to humans, where the ATP-dependent production of glutamine from glutamate and ammonia is essential for neurotransmission and ammonia detoxification. Here, we show that mammalian GS uses glutamate and methylamine to produce a methylated glutamine analog, N5-methylglutamine. Untargeted metabolomics revealed that liver-specific GS deletion and its pharmacological inhibition in mice suppress hepatic and circulating levels of N5-methylglutamine. This alternative activity of GS was confirmed in human recombinant enzyme and cells, where a pathogenic mutation in the active site (R324C) promoted the synthesis of N5-methylglutamine over glutamine. N5-methylglutamine is detected in the circulation, and its levels are sustained by the microbiome, as demonstrated by using germ-free mice. Finally, we show that urine levels of N5-methylglutamine correlate with tumor burden and GS expression in a β-catenin-driven model of liver cancer, highlighting the translational potential of this uncharacterized metabolite. | |
dc.format.extent | 13 | |
dc.format.extent | 6983693 | |
dc.language.iso | eng | |
dc.relation.ispartof | Nature Chemical Biology | en |
dc.subject | QH301 Biology | en |
dc.subject | RC0254 Neoplasms. Tumors. Oncology (including Cancer) | en |
dc.subject | DAS | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | MCC | en |
dc.subject.lcc | QH301 | en |
dc.subject.lcc | RC0254 | en |
dc.title | Hepatic glutamine synthetase controls N5-methylglutamine in homeostasis and cancer | en |
dc.type | Journal article | en |
dc.contributor.institution | University of St Andrews. School of Medicine | en |
dc.contributor.institution | University of St Andrews. School of Physics and Astronomy | en |
dc.contributor.institution | University of St Andrews. Sir James Mackenzie Institute for Early Diagnosis | en |
dc.contributor.institution | University of St Andrews. Cellular Medicine Division | en |
dc.identifier.doi | https://doi.org/10.1038/s41589-022-01154-9 | |
dc.description.status | Peer reviewed | en |
This item appears in the following Collection(s)
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.